Personal information

Activities

Employment (1)

University of Rome Tor Vergata: Rome, Lazio, IT

2022-01-01 to present | PhD student (Biology)
Employment
Source: Self-asserted source
Veronica Venafra

Education and qualifications (2)

University of Rome Tor Vergata: Rome, Lazio, IT

Bachelor degree in Biotechnology (Biology)
Education
Source: Self-asserted source
Veronica Venafra

University of Rome Tor Vergata: Rome, Lazio, IT

Master degree in Bioinformatics (Biology)
Education
Source: Self-asserted source
Veronica Venafra

Works (15)

NetworkCommons: bridging data, knowledge, and methods to build and evaluate context-specific biological networks

Bioinformatics
2025-02-04 | Journal article
Contributors: Victor Paton; Denes Türei; Olga Ivanova; Sophia Müller-Dott; Pablo Rodriguez-Mier; Veronica Venafra; Livia Perfetto; Martin Garrido-Rodriguez; Julio Saez-Rodriguez; Jianlin Cheng
Source: check_circle
Crossref

NetworkCommons: bridging data, knowledge and methods to build and evaluate context-specific biological networks

2024-11-25 | Preprint
Contributors: Victor Paton; Denes Türei; Olga Ivanova; Sophia Müller-Dott; Pablo Rodriguez-Mier; Veronica Venafra; Livia Perfetto; Martin Garrido-Rodriguez; Julio Saez-Rodriguez
Source: check_circle
Crossref

Data from Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses

2024-06-03 | Preprint
Contributors: Anna Morena D'Alise; Guido Leoni; Gabriella Cotugno; Loredana Siani; Rosa Vitale; Valentino Ruzza; Irene Garzia; Laura Antonucci; Elisa Micarelli; Veronica Venafra et al.
Source: check_circle
Crossref

Data from Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses

2024-06-03 | Preprint
Contributors: Anna Morena D'Alise; Guido Leoni; Gabriella Cotugno; Loredana Siani; Rosa Vitale; Valentino Ruzza; Irene Garzia; Laura Antonucci; Elisa Micarelli; Veronica Venafra et al.
Source: check_circle
Crossref

Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses

Clinical Cancer Research
2024-06-03 | Journal article
Contributors: Anna Morena D'Alise; Guido Leoni; Gabriella Cotugno; Loredana Siani; Rosa Vitale; Valentino Ruzza; Irene Garzia; Laura Antonucci; Elisa Micarelli; Veronica Venafra et al.
Source: check_circle
Crossref

Supplementary Figure 1 from Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses

2024-06-03 | Preprint
Contributors: Anna Morena D'Alise; Guido Leoni; Gabriella Cotugno; Loredana Siani; Rosa Vitale; Valentino Ruzza; Irene Garzia; Laura Antonucci; Elisa Micarelli; Veronica Venafra et al.
Source: check_circle
Crossref

Supplementary Figure 1 from Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses

2024-06-03 | Preprint
Contributors: Anna Morena D'Alise; Guido Leoni; Gabriella Cotugno; Loredana Siani; Rosa Vitale; Valentino Ruzza; Irene Garzia; Laura Antonucci; Elisa Micarelli; Veronica Venafra et al.
Source: check_circle
Crossref

Supplementary Table 1 from Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses

2024-06-03 | Preprint
Contributors: Anna Morena D'Alise; Guido Leoni; Gabriella Cotugno; Loredana Siani; Rosa Vitale; Valentino Ruzza; Irene Garzia; Laura Antonucci; Elisa Micarelli; Veronica Venafra et al.
Source: check_circle
Crossref

Supplementary Table 1 from Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses

2024-06-03 | Preprint
Contributors: Anna Morena D'Alise; Guido Leoni; Gabriella Cotugno; Loredana Siani; Rosa Vitale; Valentino Ruzza; Irene Garzia; Laura Antonucci; Elisa Micarelli; Veronica Venafra et al.
Source: check_circle
Crossref

Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction

eLife
2024-04-02 | Journal article
Contributors: Sara Latini; Veronica Venafra; Giorgia Massacci; Valeria Bica; Simone Graziosi; Giusj Monia Pugliese; Marta Iannuccelli; Filippo Frioni; Gessica Minnella; John Donald Marra et al.
Source: check_circle
Crossref

Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction

eLife
2024-04-02 | Journal article
Contributors: Sara Latini; Veronica Venafra; Giorgia Massacci; Valeria Bica; Simone Graziosi; Giusj Monia Pugliese; Marta Iannuccelli; Filippo Frioni; Gessica Minnella; John Donald Marra et al.
Source: check_circle
Crossref

SignalingProfiler2.0: a network-based approach to bridge multi-omics data to phenotypic hallmarks

2024-01-29 | Preprint
Contributors: Veronica Venafra; Francesca Sacco; Livia Perfetto
Source: check_circle
Crossref

Impact of FLT3-ITD location on cytarabine sensitivity in AML: a network-based approach

Leukemia
2023-05 | Journal article
Contributors: Giusj Monia Pugliese; Veronica Venafra; Valeria Bica; Giorgia Massacci; Sara Latini; Simone Graziosi; Thomas Fischer; Dimitrios Mougiakakos; Martin Boettcher; Livia Perfetto et al.
Source: check_circle
Crossref

A key role of the WEE1-CDK1 axis in mediating TKI-therapy resistance in FLT3-ITD positive acute myeloid leukemia patients

Leukemia
2023-02 | Journal article
Contributors: Giorgia Massacci; Veronica Venafra; Sara Latini; Valeria Bica; Giusj Monia Pugliese; Simone Graziosi; Felix Klingelhuber; Natalie Krahmer; Thomas Fischer; Dimitrios Mougiakakos et al.
Source: check_circle
Crossref

A key role of the WEE1-CDK1 axis in mediating TKI-therapy resistance in FLT3-ITD positive acute myeloid leukemia patients

2022-05-16 | Preprint
Contributors: Giorgia Massacci; Veronica Venafra; Sara Latini; Valeria Bica; Giusj Monia Pugliese; Felix Klingelhuber; Natalie Krahmer; Thomas Fischer; Dimitrios Mougiakakos; Martin Boettcher et al.
Source: check_circle
Crossref